| Dr Jon-paul Philip Dimauro, MD | |
|
269-01 76th Avenue, 365, New Hyde Park, NY 11040-0000 | |
| (718) 470-3570 | |
| (718) 470-3472 |
| Full Name | Dr Jon-paul Philip Dimauro |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
| Location | 269-01 76th Avenue, New Hyde Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477794584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XP3100X | Orthopaedic Surgery - Pediatric Orthopaedic Surgery | 261077-1 (New York) | Primary |
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
People who have obstructive sleep apnea - when a person stops breathing for periods during sleep - have a greater risk of sudden cardiac death, according to a study published online today in the Journal of the American College of Cardiology.
A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team led by Prof. Lukas Kenner from the Medical University of Vienna, the Veterinary University of Vienna, and the Ludwig Boltzmann Institiute for Cancer Research (LBI-CR) discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jon-paul Philip Dimauro, MD 269-01 76th Avenue, 365, New Hyde Park, NY 11040-0000 Ph: (718) 470-3570 | Dr Jon-paul Philip Dimauro, MD 269-01 76th Avenue, 365, New Hyde Park, NY 11040-0000 Ph: (718) 470-3570 |
News Archive
People who have obstructive sleep apnea - when a person stops breathing for periods during sleep - have a greater risk of sudden cardiac death, according to a study published online today in the Journal of the American College of Cardiology.
A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team led by Prof. Lukas Kenner from the Medical University of Vienna, the Veterinary University of Vienna, and the Ludwig Boltzmann Institiute for Cancer Research (LBI-CR) discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
POZEN Inc. announced today the results of a Phase I study that showed a novel, investigational combination of enteric-coated aspirin (EC-ASA) and immediate-release omeprazole known as PA65020, is associated with a significantly decreased risk of GI mucosal damage compared to analgesic doses (650 mg twice daily) of over-the-counter enteric-coated aspirin (EC-ASA) in healthy adults treated for one month.
› Verified 3 days ago
Alexander Volpi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave Ste 102, New Hyde Park, NY 11042 Phone: 914-260-5459 | |
John E Handelsman, M.D.,FRCS,MCH.ORTH Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1999 Marcus Ave Ste 200, New Hyde Park, NY 11042 Phone: 516-467-8600 | |
Dr. Allison Brooke Spitzer, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 7 Vermont Drive, Center For Pediatric Orthopaedic Surgery, New Hyde Park, NY 11042 Phone: 516-210-8400 | |
Maury Harris, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Road, Suite 209, New Hyde Park, NY 11042 Phone: 516-358-2121 | |
Raymond A Shebairo, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1575 Hillside Ave, Ste 303, New Hyde Park, NY 11040 Phone: 516-437-5500 Fax: 516-358-5359 | |
Dr. Shachar Kenan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 270-05 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7000 | |
Dr. Kenneth Mark Kamler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Suite 100, New Hyde Park, NY 11042 Phone: 516-326-8810 Fax: 516-328-7165 |